06/02/2025 15:15
Corcept Presents Pivotal Clinical Data in ASCO Late-Breaker with Simultaneous Publication in The Lancet: Relacorilant Improves Progression-Free and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today shared data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer in a late-breaking oral presentation at the ASCO 2025 (American Society of Clinical Oncology)...

06/02/2025 15:23
STEMCELL Technologies Announces Acquisition of Cellular Highways

STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways Ltd from TTP Group Ltd. Cellular Highways is a biotechnology company based near Cambridge, United Kingdom, that specializes in advanced cell sorting technologies with applications in cell and gene therapy, drug discovery, and general cell research, especially where cells are fragile. This press release features multimedia. View the full release here: https://www.businesswi...

06/11/2025 11:50
Public Sector Application Risk Accumulates as Security Debt Grows Across Government Systems

Veracode, a global leader in application risk management, today released its Public Sector State of Software Security 2025 report, revealing alarming trends in software security across government organizations. Drawing from an extensive analysis of 1.3 million unique applications and 126.4 million raw findings, the research shows 78 percent of public sector organizations are operating with significant security debt—flaws left unaddressed for more than a year. Moreover, 55 percent are burdened w...

06/26/2025 10:00
BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day

In a significant showcase for investors, BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will announce major advancements to its industry-leading oncology pipeline during today’s investor R&D Day. The event comes at a pivotal moment for the Company, which has more than 40 clinical and commercial stage assets in development, a signal of both scale and ambition. “At BeOne, our mission is simple yet bold: to create the world’s first next-generation on...

06/26/2025 10:00
Mercans Unveils Strategic Innovations to Enhance Global Payroll and AI-Powered Client Experience

Mercans, a global leader in payroll technology, today announced three significant developments aimed at strengthening its service offerings and enhancing client experiences: the establishment of a Payroll Compliance Center of Excellence (CoE), the integration of HiBob into its technology ecosystem, and the launch of an AI-powered Digital Sales Room (DSR). Establishment of Payroll Compliance Center of Excellence In response to the increasing complexity of global payroll regulations, Mercans ...

07/09/2025 13:00
Rimini Street to Report Second Quarter 2025 Financial Results on July 31, 2025

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced it will report earnings after market close on July 31, 2025. The company will host a conference call and webcast on that date to discuss the second quarter 2025 results and the 2025 outlook at 5:00 p.m. Eastern / 2:00 p.m. Pacific time. This press release features m...

07/09/2025 13:00
Obsidian Security Expands Go-to-Market Leadership Team to Scale SaaS Protection in the Age of AI

Obsidian Security, the leading SaaS security platform trusted by global enterprises including Snowflake, T-Mobile, and Pure Storage, today announced the expansion of its go-to-market leadership team with five strategic appointments. These hires position Obsidian to scale its operations as the company addresses the rapidly evolving security challenges posed by agentic AI and accelerates toward long-term growth and IPO readiness. The company has appointed Alison Tierney as VP of Go-to-Market (G...

06/24/2025 06:43
SWARM Biotactics Raised €13M to Advance Bio-Robotics From Lab to Field

SWARM Biotactics, developer of bio-robotic systems based on fully controllable living insects for mission-critical operations, has secured €10 million in seed funding, bringing its total raised to €13 million, including a €3 million pre-seed. The round was backed by a consortium of international investors from Europe, the United States, and Australia, including Vertex Ventures US, Possible Ventures, and Capnamic, who was the first investor in the pre-seed round. Several early backers also incre...